minerva surgical, inc. is a medical device start-up company based in the silicon valley; redwood city, ca. the company's efforts are focused on women's healthcare. currently, minerva surgical's development projects are aimed at delivering next generation products for the treatment of abnormal uterine bleeding, a condition that affects almost 1 in 5 women. the company was founded in 2008 by a group of experienced medical device industry veterans. these founders have successfully delivered numerous medical device based therapies to patients over a span of 30 years.
Company profile
Ticker
UTRS
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
IRS number
263422906
UTRS stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
4 Jan 24
25
Voluntary exchange delisting
26 Dec 23
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Dec 23
8-K
Minerva Surgical, Inc. Announces Voluntary SEC Deregistration and Nasdaq Delisting
15 Dec 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Minerva Surgical Reports Third Quarter 2023 Financial Results
13 Nov 23
SC 13E3/A
Going private transaction (amended)
2 Nov 23
8-K
Other Events
1 Nov 23
8-K
Departure of Directors or Certain Officers
13 Oct 23
8-K
Material Modifications to Rights of Security Holders
29 Sep 23
Transcripts
UTRS
Earnings call transcript
2023 Q2
3 Aug 23
UTRS
Earnings call transcript
2023 Q1
2 May 23
UTRS
Earnings call transcript
2022 Q4
21 Mar 23
UTRS
Earnings call transcript
2022 Q3
15 Nov 22
UTRS
Earnings call transcript
2022 Q2
13 Aug 22
UTRS
Earnings call transcript
2022 Q1
15 May 22
UTRS
Earnings call transcript
2021 Q4
8 Mar 22
Latest ownership filings
SC 13D/A
Accelmed Partners II L.P.
28 Sep 23
SC 13D/A
NEW ENTERPRISE ASSOCIATES 13 LP
7 Jul 23
SC 13D/A
Accelmed Partners II L.P.
6 Jul 23
SC 13G/A
AWM Investment Company, Inc.
10 May 23
3
Daniel Cohen
14 Mar 23
SC 13D/A
NEW ENTERPRISE ASSOCIATES 13 LP
21 Feb 23
SC 13G
AWM Investment Company, Inc.
14 Feb 23
4
PATRICK J KERINS
10 Feb 23
SC 13G/A
CVF, LLC
10 Feb 23
SC 13D
Accelmed Partners II L.P.
9 Feb 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 11.47 mm | 11.47 mm | 11.47 mm | 11.47 mm | 11.47 mm | 11.47 mm |
Cash burn (monthly) | 1.70 mm | 994.25 k | 2.39 mm | 2.78 mm | 1.70 mm | 3.23 mm |
Cash used (since last report) | 11.63 mm | 6.79 mm | 16.33 mm | 18.99 mm | 11.59 mm | 22.03 mm |
Cash remaining | -159.42 k | 4.68 mm | -4.86 mm | -7.52 mm | -120.75 k | -10.56 mm |
Runway (months of cash) | -0.1 | 4.7 | -2.0 | -2.7 | -0.1 | -3.3 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 22 |
Opened positions | 6 |
Closed positions | 7 |
Increased positions | 2 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 9.46 bn |
Total shares | 201.69 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Accelmed Partners II | 122.19 mm | $0.00 |
New Enterprise Associates 13 | 34.44 mm | $14.12 mm |
NEA Management | 34.44 mm | $8.82 bn |
CNVT CVF | 2.26 mm | $0.00 |
Vivo Ventures Vii | 2.22 mm | $20.72 mm |
AWM Investment | 2.11 mm | $0.00 |
Versant Venture Capital IV | 1.67 mm | $8.60 mm |
Versant Venture Management | 1.67 mm | $428.80 mm |
STT State Street | 161.80 k | $41.44 mm |
Geode Capital Management | 128.75 k | $32.97 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Feb 23 | New Enterprise Associates 13 | Common Stock | Buy | Acquire P | No | No | 0.2046 | 24,437,927 | 5.00 mm | 34,437,052 |